BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 35690523)

  • 1. Prediction Model and Nomogram of Early Recurrence of Hepatocellular Carcinoma after Radiofrequency Ablation Based on Logistic Regression Analysis.
    Ni Z; Wu B; Li M; Han X; Hao X; Zhang Y; Cheng W; Guo C
    Ultrasound Med Biol; 2022 Sep; 48(9):1733-1744. PubMed ID: 35690523
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Analysis of risk factors and construction of predictive nomogram for early recurrence after radiofrequency ablation of hepatocellular carcinoma].
    Han RC; Ma XH; Wang S; Yang Y; Feng B; Liang M; Zhao XM
    Zhonghua Zhong Liu Za Zhi; 2021 May; 43(5):546-552. PubMed ID: 34034474
    [No Abstract]   [Full Text] [Related]  

  • 3. Quantitative dynamic contrast-enhanced ultrasound to predict intrahepatic recurrence of hepatocellular carcinoma after radiofrequency ablation: a cohort study.
    Han X; Dong J; Liu Z; Wu B; Tian Y; Tan H; Cheng W
    Int J Hyperthermia; 2020; 37(1):1066-1073. PubMed ID: 32924654
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term survival of hepatocellular carcinoma after percutaneous radiofrequency ablation guided by ultrasound.
    Zhang W; Luo E; Gan J; Song X; Bao Z; Zhang H; Chen M
    World J Surg Oncol; 2017 Jul; 15(1):122. PubMed ID: 28679433
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel nomogram for prediction of intrahepatic recurrence-free survival in patients with HCC followed by radiofrequency ablation.
    Wang B; Wu H; Wang S; Zhang ZY; Wu W; Yan K; Yang W
    Br J Radiol; 2024 Mar; 97(1156):844-849. PubMed ID: 38346708
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Irregular vascular pattern by contrast-enhanced ultrasonography and high serum Lens culinaris agglutinin-reactive fraction of alpha-fetoprotein level predict poor outcome after successful radiofrequency ablation in patients with early-stage hepatocellular carcinoma.
    Takada H; Tsuchiya K; Yasui Y; Nakakuki N; Tamaki N; Suzuki S; Nakanishi H; Itakura J; Takahashi Y; Kurosaki M; Asahina Y; Enomoto N; Izumi N
    Cancer Med; 2016 Nov; 5(11):3111-3120. PubMed ID: 27748052
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heterogeneous type 4 enhancement of hepatocellular carcinoma on dynamic CT is associated with tumor recurrence after radiofrequency ablation.
    Kawamura Y; Ikeda K; Seko Y; Hosaka T; Kobayashi M; Saitoh S; Kumada H
    AJR Am J Roentgenol; 2011 Oct; 197(4):W665-73. PubMed ID: 21940538
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictive value of quantitative contrast-enhanced ultrasound in hepatocellular carcinoma recurrence after ablation.
    Gao Y; Zheng DY; Cui Z; Ma Y; Liu YZ; Zhang W
    World J Gastroenterol; 2015 Sep; 21(36):10418-26. PubMed ID: 26420968
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predicting cancer-specific mortality in T1/2 hepatocellular carcinoma after radiofrequency ablation by competing risk nomogram: A population-based analysis.
    He Q; Xiong Y; Xia P; Yang X; Yu Y; Chen Z
    Clin Res Hepatol Gastroenterol; 2024 Feb; 48(2):102283. PubMed ID: 38219821
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nomogram Based on Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio to Predict Recurrence in Patients with Hepatocellular Carcinoma after Radiofrequency Ablation.
    Chen Y; Yang Y; Zhang XY; Fan QS; Li X; Xin YJ; Cao XJ; Wang YN; Zhou X
    Cardiovasc Intervent Radiol; 2021 Oct; 44(10):1551-1560. PubMed ID: 34036405
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early recurrence after radiofrequency ablation for hepatocellular carcinoma: a multicenter retrospective study on definition, patterns and risk factors.
    Yang Y; Xin Y; Ye F; Liu N; Zhang X; Wang Y; Li X; Fan Q; Zhou X; Chen Y
    Int J Hyperthermia; 2021; 38(1):437-446. PubMed ID: 33724137
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcomes of radiofrequency ablation as first-line therapy for hepatocellular carcinoma less than 3 cm in potentially transplantable patients.
    Doyle A; Gorgen A; Muaddi H; Aravinthan AD; Issachar A; Mironov O; Zhang W; Kachura J; Beecroft R; Cleary SP; Ghanekar A; Greig PD; McGilvray ID; Selzner M; Cattral MS; Grant DR; Lilly LB; Selzner N; Renner EL; Sherman M; Sapisochin G
    J Hepatol; 2019 May; 70(5):866-873. PubMed ID: 30615906
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fusion imaging-guided radiofrequency ablation for residual hepatocellular carcinoma invisible on ultrasound after transcatheter arterial chemoembolization.
    Gu JH; Zhao QY; He C; Ye ZD; Xu M; Jiang TA
    Int J Hyperthermia; 2021; 38(1):1092-1098. PubMed ID: 34296656
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Virtual navigation-guided radiofrequency ablation for recurrent hepatocellular carcinoma invisible on ultrasound after hepatic resection.
    Zhao QY; Xie LT; Chen SC; Xu X; Jiang TA; Zheng SS
    Hepatobiliary Pancreat Dis Int; 2020 Dec; 19(6):532-540. PubMed ID: 33020034
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New nomogram predicts the recurrence of hepatocellular carcinoma in patients with negative preoperative serum AFP subjected to curative resection.
    Gan W; Huang JL; Zhang MX; Fu YP; Yi Y; Jing CY; Fan J; Zhou J; Qiu SJ
    J Surg Oncol; 2018 Jun; 117(7):1540-1547. PubMed ID: 29572833
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Construction of a novel radiomics nomogram for the prediction of aggressive intrasegmental recurrence of HCC after radiofrequency ablation.
    Lv X; Chen M; Kong C; Shu G; Meng M; Ye W; Cheng S; Zheng L; Fang S; Chen C; Wu F; Weng Q; Tu J; Zhao Z; Ji J
    Eur J Radiol; 2021 Nov; 144():109955. PubMed ID: 34600237
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Can Liver Ultrasound Elastography Predict the Risk of Hepatocellular Carcinoma Recurrence After Radiofrequency Ablation? A Systematic Review and Meta-Analysis.
    Vestito A; Dajti E; Cortellini F; Montagnani M; Bazzoli F; Zagari RM
    Ultraschall Med; 2023 Jun; 44(3):e139-e147. PubMed ID: 34758491
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Features of extrahepatic metastasis after radiofrequency ablation for hepatocellular carcinoma.
    Yoon JH; Goo YJ; Lim CJ; Choi SK; Cho SB; Shin SS; Jun CH
    World J Gastroenterol; 2020 Aug; 26(32):4833-4845. PubMed ID: 32921960
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Efficacy and Therapeutic Outcome of Bipolar Radiofrequency Ablation for the Treatment for Hepatocellular Carcinoma in the Real-World Setting, Compared with Monopolar Radiofrequency Ablation Conducted during the Same Period.
    Tanaka T; Takata K; Kunimoto H; Fukuda H; Yamauchi R; Tsuchiya N; Inomata S; Yokoyama K; Morihara D; Takeyama Y; Shakado S; Sakisaka S; Hirai F
    Oncology; 2020; 98(12):859-868. PubMed ID: 32799203
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Initial Alpha-Fetoprotein Response Predicts Prognosis in Hepatitis B-related Solitary HCC Patients After Radiofrequency Ablation.
    Yu SJ; Kwon JH; Kim W; Yoon JH; Lee JM; Lee JY; Cho EJ; Lee JH; Kim HY; Jung YJ; Kim YJ
    J Clin Gastroenterol; 2018 Mar; 52(3):e18-e26. PubMed ID: 28795996
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.